Your browser doesn't support javascript.
Clinical features and outcomes of COVID-19 admissions in a population with a high prevalence of HIV and tuberculosis: a multicentre cohort study.
Parker, Arifa; Boloko, Linda; Moolla, Muhammad S; Ebrahim, Nabilah; Ayele, Birhanu T; Broadhurst, Alistair G B; Mashigo, Boitumelo; Titus, Gideon; de Wet, Timothy; Boliter, Nicholas; Rosslee, Michael-Jon; Papavarnavas, Nectarios; Abrahams, Riezaah; Mendelson, Marc; Dlamini, Sipho; Taljaard, Jantjie J; Prozesky, Hans W; Mowlana, Abdurasiet; Viljoen, Abraham J; Schrueder, Neshaad; Allwood, Brian W; Lalla, Usha; Dave, Joel A; Calligaro, Greg; Levin, Dion; Maughan, Deborah; Ntusi, Ntobeko A B; Nyasulu, Peter S; Meintjes, Graeme; Koegelenberg, Coenraad F N; Mnguni, Ayanda T; Wasserman, Sean.
  • Parker A; Division of General Medicine, Department of Medicine, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa. aparker@sun.ac.za.
  • Boloko L; Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Moolla MS; Division of General Medicine, Department of Medicine, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.
  • Ebrahim N; Department of Medicine, Khayelitsha District Hospital, Cape Town, South Africa.
  • Ayele BT; Division of Epidemiology and Biostatistics, Department of Global Health, Stellenbosch University, Cape Town, South Africa.
  • Broadhurst AGB; Division of General Medicine, Department of Medicine, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.
  • Mashigo B; Division of General Medicine, Department of Medicine, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.
  • Titus G; Division of General Medicine, Department of Medicine, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.
  • de Wet T; Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Boliter N; Department of Medicine, Khayelitsha District Hospital, Cape Town, South Africa.
  • Rosslee MJ; Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Papavarnavas N; Division of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Abrahams R; Division of Infectious Diseases, Department of Medicine, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.
  • Mendelson M; Division of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Dlamini S; Division of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Taljaard JJ; Division of Infectious Diseases, Department of Medicine, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.
  • Prozesky HW; Division of Infectious Diseases, Department of Medicine, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.
  • Mowlana A; Division of General Medicine, Department of Medicine, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.
  • Viljoen AJ; Division of General Medicine, Department of Medicine, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.
  • Schrueder N; Division of General Medicine, Department of Medicine, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.
  • Allwood BW; Division of Pulmonology, Department of Medicine, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.
  • Lalla U; Division of Pulmonology, Department of Medicine, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.
  • Dave JA; Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Calligaro G; Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Levin D; Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Maughan D; Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Ntusi NAB; Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Nyasulu PS; Extramural Unit on Intersection on Noncommunicable Diseases and Infectious Diseases, South African Medical Research Council, Cape Town, South Africa.
  • Meintjes G; Division of Epidemiology and Biostatistics, Department of Global Health, Stellenbosch University, Cape Town, South Africa.
  • Koegelenberg CFN; Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Mnguni AT; Division of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Wasserman S; Institute for Infectious Disease and Molecular Medicine, Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Cape Town, South Africa.
BMC Infect Dis ; 22(1): 559, 2022 Jun 20.
Article in English | MEDLINE | ID: covidwho-1962757
ABSTRACT

BACKGROUND:

There is still a paucity of evidence on the outcomes of coronavirus disease 2019 (COVID-19) among people living with human immunodeficiency virus (PWH) and those co-infected with tuberculosis (TB), particularly in areas where these conditions are common. We describe the clinical features, laboratory findings and outcome of hospitalised PWH and human immunodeficiency virus (HIV)-uninfected COVID-19 patients as well as those co-infected with tuberculosis (TB).

METHODS:

We conducted a multicentre cohort study across three hospitals in Cape Town, South Africa. All adults requiring hospitalisation with confirmed COVID-19 pneumonia from March to July 2020 were analysed.

RESULTS:

PWH comprised 270 (19%) of 1434 admissions. There were 47 patients with active tuberculosis (3.3%), of whom 29 (62%) were PWH. Three-hundred and seventy-three patients (26%) died. The mortality in PWH (n = 71, 26%) and HIV-uninfected patients (n = 296, 25%) was comparable. In patients with TB, PWH had a higher mortality than HIV-uninfected patients (n = 11, 38% vs n = 3, 20%; p = 0.001). In multivariable survival analysis a higher risk of death was associated with older age (Adjusted Hazard Ratio (AHR) 1.03 95%CI 1.02-1.03, p < 0.001), male sex (AHR1.38 (95%CI 1.12-1.72, p = 0.003) and being "overweight or obese" (AHR 1.30 95%CI 1.03-1.61 p = 0.024). HIV (AHR 1.28 95%CI 0.95-1.72, p 0.11) and active TB (AHR 1.50 95%CI 0.84-2.67, p = 0.17) were not independently associated with increased risk of COVID-19 death. Risk factors for inpatient mortality in PWH included CD4 cell count < 200 cells/mm3, higher admission oxygen requirements, absolute white cell counts, neutrophil/lymphocyte ratios, C-reactive protein, and creatinine levels.

CONCLUSION:

In a population with high prevalence of HIV and TB, being overweight/obese was associated with increased risk of mortality in COVID-19 hospital admissions, emphasising the need for public health interventions in this patient population.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Tuberculosis / HIV Infections / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Humans / Male Country/Region as subject: Africa Language: English Journal: BMC Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: S12879-022-07519-8

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Tuberculosis / HIV Infections / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Humans / Male Country/Region as subject: Africa Language: English Journal: BMC Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: S12879-022-07519-8